GeoVax Labs, Inc.
Other OTC
0.080.00 (0.00%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.08
Bid0.00 x
Ask0.00 x
52wk Range0.05 - 0.14
Day's Range0.08 - 0.08
Avg Vol (3m)90,219
As of 3:50 PM EDT. Market closed.
  • Zacks Small Cap Research2 months ago

    GOVX: GeoVax: Entering into HBV Market

    By Grant Zeng, CFA OTC:GOVX On Jun 6, 2016, GeoVax (OTC:GOVX) announced the launch of a program to develop a therapeutic vaccine for treatment of chronic Hepatitis B infections (HBV). This announcement ...

  • Zacks Small Cap Research5 months ago

    GOVX: GeoVax to Develop Vaccine against Zika Virus

    GeoVax (GOVX) has been busy in the past few months expanding its pipeline into new areas. In early February, 2016, GeoVax started a program to develop a vaccine for the prevention of Zika virus infections using its novel MVA-VLP vaccine platform. Recent outbreak of Zika virus in America makes the WHO to designate the Zika virus and its suspected complications in newborns an international public health emergency.